Open AccessSafety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1-Infected Children, Adolescents, and Young Adults
Author(s) -
Patricia M. Flynn,
Sharon Nachman,
Petronella Muresan,
Terry Fenton,
Stephen A. Spector,
Coleen K. Cunningham,
Robert F. Pass,
Ram Yogev,
Sandra Burchett,
Bryan W. Heckman,
A. Anthony Bloom,
L. J. Utech,
Patricia Anthony,
Elizabeth Petzold,
Wende Levy,
George K. Siberry,
Ruth Ebiasah,
Jim Miller,
Edward Handelsman,
Amy R. Weinberg,
for the IMPAACT P Team
Publication year - 2012
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jis360
Subject(s) - immunogenicity , pandemic , vaccination , medicine , virology , young adult , human immunodeficiency virus (hiv) , live attenuated influenza vaccine , pandemic influenza , immunology , pediatrics , influenza vaccine , covid-19 , antibody , disease , infectious disease (medical specialty)
The safety and immunogenicity of high-dose pandemic H1N1 (pH1N1) vaccination in perinatally human immunodeficiency virus type 1 (HIV-1)-infected children, adolescents, and young adults are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom